Luna Innovations Incorporated (LUNA) financial statements (2020 and earlier)
Company profile
| Business Address |
301 FIRST STREET SW ROANOKE, VA 24011 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 25 | 42 | 37 | 13 | 17 | 14 | 8 | ||
| Cash and cash equivalents | 25 | 42 | 37 | 13 | 17 | 14 | 8 | ||
| Receivables | 19 | 16 | 14 | 14 | 11 | 6 | 5 | ||
| Inventory, net of allowances, customer advances and progress billings | 10 | 7 | 7 | 8 | 9 | 3 | 3 | ||
| Inventory | 10 | 7 | 7 | 8 | 9 | 3 | 3 | ||
| Prepaid expense | 1 | 1 | |||||||
| Contract with customer, asset | 3 | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other current assets | 0 | 0 | |||||||
| Other undisclosed current assets | 1 | 1 | 1 | 2 | 1 | ||||
| Total current assets: | 58 | 68 | 59 | 37 | 39 | 24 | 17 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 3 | 4 | 3 | 7 | 7 | 3 | 2 | ||
| Intangible assets, net (including goodwill) | 21 | 3 | 4 | 11 | 13 | 0 | 0 | ||
| Goodwill | 11 | 0 | 1 | 2 | 2 | ||||
| Intangible assets, net (excluding goodwill) | 10 | 3 | 3 | 9 | 10 | 0 | 0 | ||
| Contract with customer, asset, net | 0 | 0 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Deferred income tax assets | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other noncurrent assets | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total noncurrent assets: | 28 | 7 | 7 | 18 | 19 | 4 | 2 | ||
| TOTAL ASSETS: | 87 | 76 | 66 | 55 | 58 | 28 | 20 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 13 | 9 | 12 | 13 | 12 | 10 | 5 | ||
| Accounts payable | 3 | 2 | 3 | 4 | 4 | 1 | 1 | ||
| Accrued liabilities | 10 | 7 | 9 | 9 | 8 | 6 | 1 | ||
| Employee-related liabilities | 2 | 2 | |||||||
| Taxes payable | 0 | ||||||||
| Deferred revenue | 4 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Debt | 1 | 2 | 2 | 2 | 1 | 2 | |||
| Deferred revenue and credits | ✕ | ✕ | 1 | 1 | 1 | 1 | 1 | ||
| Contract with customer, liability | ✕ | 2 | ✕ | ✕ | ✕ | ✕ | ✕ | ||
| Other undisclosed current liabilities | (3) | 0 | |||||||
| Total current liabilities: | 17 | 12 | 15 | 16 | 15 | 9 | 7 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | 1 | 3 | 4 | 0 | 1 | |||
| Long-term debt, excluding current maturities | 1 | 2 | 4 | 1 | |||||
| Capital lease obligations | ✕ | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Liabilities, other than long-term debt | 2 | 1 | 1 | 1 | 2 | ||||
| Deferred revenue and credits | ✕ | ✕ | 1 | 1 | 2 | ||||
| Deferred rent credit | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other liabilities | 2 | ||||||||
| Total noncurrent liabilities: | 2 | 1 | 2 | 4 | 6 | 0 | 1 | ||
| Total liabilities: | 19 | 13 | 17 | 20 | 21 | 9 | 8 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 67 | 62 | 50 | 35 | 37 | 19 | 12 | ||
| Preferred stock | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (4) | (2) | (2) | (1) | (0) | (0) | |||
| Additional paid in capital | 88 | 86 | 84 | 82 | 81 | 64 | 63 | ||
| Accumulated deficit | (16) | (21) | (32) | (47) | (44) | (45) | (51) | ||
| Total stockholders' equity: | 67 | 62 | 50 | 35 | 37 | 19 | 12 | ||
| TOTAL LIABILITIES AND EQUITY: | 87 | 76 | 66 | 55 | 58 | 28 | 20 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 71 | 43 | 46 | 59 | 44 | 21 | 22 | |
| Revenue, net | ✕ | ✕ | 46 | 59 | 44 | 21 | 22 | |
| Cost of revenue | (35) | (23) | (28) | (37) | (28) | (13) | (14) | |
| Cost of goods and services sold | (35) | (23) | (14) | (13) | (10) | (10) | (9) | |
| Gross profit: | 35 | 19 | 18 | 22 | 17 | 8 | 8 | |
| Operating expenses | (32) | (19) | (18) | (24) | (23) | (12) | (14) | |
| Operating income (loss): | 3 | 1 | (0) | (2) | (6) | (5) | (6) | |
| Nonoperating income (expense) | 0 | 0 | (0) | (0) | (0) | 0 | 0 | |
| Investment income, nonoperating | 0 | 1 | ||||||
| Other nonoperating income (expense) | (0) | (0) | (0) | (0) | (0) | 0 | 0 | |
| Interest and debt expense | (0) | (0) | (0) | (0) | (0) | (0) | (0) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Income (loss) from continuing operations before income taxes: | 4 | 1 | (0) | (2) | (6) | (4) | (6) | |
| Income tax expense (benefit) | 2 | (0) | 0 | (0) | 0 | 1 | 1 | |
| Income (loss) from continuing operations: | 5 | 1 | (0) | (2) | (6) | (3) | (4) | |
| Income from discontinued operations | 10 | 15 | 8 | 9 | 3 | |||
| Net income (loss) attributable to parent: | 5 | 11 | 15 | (2) | 2 | 6 | (1) | |
| Preferred stock dividends and other adjustments | (0) | (0) | (0) | (0) | (0) | (0) | (0) | |
| Net income (loss) available to common stockholders, diluted: | 5 | 11 | 14 | (2) | 2 | 6 | (1) | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | 5 | 11 | 15 | (2) | 2 | 6 | (1) | |
| Comprehensive income (loss), net of tax, attributable to parent: | 5 | 11 | 15 | (2) | 2 | 6 | (1) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.